Objective: Artificial intelligence and machine learning are transforming many fields including
medicine. In diabetes, robust biosensing technologies and automated insulin delivery …

Wearable continuous glucose monitoring (CGM) sensors are revolutionizing the treatment of
type 1 diabetes (T1D). These sensors provide in real-time, every 1–5 min, the current blood …

Background: Wrist-worn activity monitors are often used to monitor heart rate (HR) and
energy expenditure (EE) in a variety of settings including more recently in medical …

Diabetes patients suffer from abnormal blood glucose levels, which can cause diverse
health disorders that affect their kidneys, heart and vision. Due to these conditions, diabetes …

The artificial pancreas is a long-awaited goal for the management of type 1 diabetes, and its
development was recently triggered by the development of continuous glucose sensors …

Recent, rapid changes in the treatment of type 1 diabetes have allowed for
commercialization of an “artificial pancreas” that is better described as a closed-loop …

In this article, we present several important contributions necessary for enabling an artificial
endocrine pancreas (AP) system to better respond to exercise events. First, we show how …

Objective Artificial pancreas (AP) systems have been shown to improve glycemic control
throughout the day and night in adults, adolescents, and children. However, AP testing …

Diabetic foot ulcers (DFUs) are one of the most serious complications of diabetes mellitus
(DM). Although research has improved understanding of DFU etiology, an effective clinical …

Background: Fear of exercise related hypoglycemia is a major reason why people with type
1 diabetes (T1D) do not exercise. There is no validated prediction algorithm that can predict …